Therefore, in this study, we evaluated if clinical features correlate with p53 levels previously analysed by IHC in 108 breast cancers [64], comprising 31 Grade 1, 24 Grade 2, and 53 Grade-invasive ductal carcinomas (IDCs) [64]. The gene discussed is TP53; the disease is invasive ductal breast carcinoma.